{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:53:54Z","timestamp":1788893634045,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Conacyt","award":["CB-2012\/179294"],"award-info":[{"award-number":["CB-2012\/179294"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.pharep.2014.12.006","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T05:29:52Z","timestamp":1419053392000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Celecoxib reduces hyperalgesia and tactile allodynia in diabetic rats"],"prefix":"10.1007","volume":"67","author":[{"given":"Isela E.","family":"Ju\u00e1rez-Rojop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina E.","family":"Morales-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Tovilla-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deysi Y.","family":"Berm\u00fadez-Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Torres-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Ble-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"D\u00edaz-Zagoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicio","family":"Granados-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(99)00112-6","article-title":"Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life","volume":"47","author":"Galer","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3810\/pgm.2012.07.2576","article-title":"Diabetic peripheral neuropathy and the management of diabetic peripheral neuropathic pain","volume":"124","author":"Morales-Vidal","year":"2012","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0306-4522(00)00052-X","article-title":"Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats","volume":"97","author":"Zhao","year":"2000","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.pharep.2014.12.006_bib0025","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00000542-200311000-00027","article-title":"Inhibition of spinal prostaglandin synthesis early after L5\/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat","volume":"99","author":"Hefferan","year":"2003","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2004.03.040","article-title":"Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats","volume":"363","author":"Takahashi","year":"2004","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pbb.2004.08.005","article-title":"Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats","volume":"79","author":"Padi","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00115550-200507000-00007","article-title":"Systemic meloxicam reduces tactile allodynia development after L5 single spinal nerve injury in rats","volume":"30","author":"Takahashi","year":"2005","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3959(94)90218-6","article-title":"Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics","volume":"57","author":"Courteix","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.expneurol.2003.09.015","article-title":"Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat","volume":"185","author":"Schafers","year":"2004","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2009.06.037","article-title":"Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats","volume":"57","author":"Yamamoto","year":"2009","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharep.2014.12.006_bib0060","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2337\/diabetes.51.7.2249","article-title":"Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats","volume":"51","author":"Freshwater","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0065","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0306-4522(03)00495-0","article-title":"Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury","volume":"121","author":"Ma","year":"2003","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pharep.2014.12.006_bib0070","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neurobiolaging.2008.08.002","article-title":"Injured nerve-derived COX2\/PGE2 contributes to the maintenance of neuropathic pain in aged rats","volume":"31","author":"Ma","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.pharep.2014.12.006_bib0075","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2337\/db06-1269","article-title":"Pathogenesis of spinally mediated hyperalgesia in diabetes","volume":"56","author":"Ramos","year":"2007","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2004.03.014","article-title":"Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model","volume":"1010","author":"Suyama","year":"2004","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/jpet.104.075267","article-title":"The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-bpyridazine] is effective in animal models of neuropathic pain and central sensitization","volume":"312","author":"Bingham","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pain.2006.08.032","article-title":"GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury","volume":"128","author":"Zhao","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0095","doi-asserted-by":"crossref","first-page":"e54797","DOI":"10.1371\/journal.pone.0054797","article-title":"The role of potassium channel activation in celecoxib-induced analgesic action","volume":"8","author":"Mi","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2006.09.072","article-title":"Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats","volume":"554","author":"Matsunaga","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1254\/jphs.09006SC","article-title":"Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice","volume":"110","author":"Kimura","year":"2009","journal-title":"J Pharmacol Sci"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2014.12.006_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2011.04.044","article-title":"Proglumide enhances the antinociceptive effect of cyclooxygenase inhibitors in diabetic rats in the formalin test","volume":"664","author":"Bermudez-Ocana","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2005.02.004","article-title":"COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites","volume":"107","author":"Burian","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2014.12.006_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00003643-199705001-00003","article-title":"Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs","volume":"15","author":"Bovill","year":"1997","journal-title":"Eur J Anaesthesiol Suppl"},{"issue":"9","key":"10.1016\/j.pharep.2014.12.006_bib0125","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-ylbenze nesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J Med Chem"},{"issue":"3\u20134","key":"10.1016\/j.pharep.2014.12.006_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000336346","article-title":"Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system","volume":"89","author":"Rezende","year":"2012","journal-title":"Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pain.2008.12.005","article-title":"The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids","volume":"142","author":"Rezende","year":"2009","journal-title":"Pain"},{"issue":"25\u201326","key":"10.1016\/j.pharep.2014.12.006_bib0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.lfs.2010.04.012","article-title":"Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia","volume":"86","author":"Correa","year":"2010","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000110787","article-title":"Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats","volume":"81","author":"Bujalska","year":"2008","journal-title":"Pharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2014.12.006_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2012.12.015","article-title":"Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models","volume":"700","author":"Wagner","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain","volume":"53","author":"Courteix","year":"1993","journal-title":"Pain"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2014.12.006_bib0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2005.10.016","article-title":"Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats","volume":"527","author":"Araiza-Saldana","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pain.2006.01.018","article-title":"Involvement of cholecystokinin in peripheral nociceptive sensitization during diabetes in rats as revealed by the formalin response","volume":"122","author":"Juarez-Rojop","year":"2006","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","article-title":"Standardization of the rat paw formalin test for the evaluation of analgesics","volume":"104","author":"Wheeler-Aceto","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2014.12.006_bib0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2014.12.006_bib0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2007.09.006","article-title":"Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats","volume":"577","author":"Arreola-Espino","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/np3007342","article-title":"Evidence for the involvement of descending pain-inhibitory mechanisms in the antinociceptive effect of hecogenin acetate","volume":"76","author":"Gama","year":"2013","journal-title":"J Natural Prod"},{"issue":"6","key":"10.1016\/j.pharep.2014.12.006_bib0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bjp.0704937","article-title":"Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation","volume":"137","author":"Francischi","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2006.02.012","article-title":"Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan","volume":"51","author":"Franca","year":"2006","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharep.2013.12.011","article-title":"Pharmacological characterization of carrageenan induced heat muscle hyperalgesia in rats using non-selective, preferential and selective COX-2 inhibitors","volume":"66","author":"Chopade","year":"2014","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0215","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1399-6576.2006.00921.x","article-title":"Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats","volume":"50","author":"Nishiyama","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0220","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/00000539-200204000-00035","article-title":"The role of cyclooxygenase-1 and -2 in the rat formalin test","volume":"94","author":"Yamamoto","year":"2002","journal-title":"Anesth Analg"},{"issue":"12","key":"10.1016\/j.pharep.2014.12.006_bib0225","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1745-7254.2005.00222.x","article-title":"Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2\/1","volume":"26","author":"Lu","year":"2005","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2004.05.058","article-title":"Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain","volume":"1018","author":"Rodrigues-Filho","year":"2004","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.pharep.2014.12.006_bib0235","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"issue":"11\u201312","key":"10.1016\/j.pharep.2014.12.006_bib0240","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/ars.2005.7.1521","article-title":"Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress","volume":"7","author":"Kellogg","year":"2005","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.pharep.2014.12.006_bib0245","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1476-5381.2011.01483.x","article-title":"Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels","volume":"164","author":"Du","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2012.03.032","article-title":"Role of ATP-sensitive K+ channels in the antinociception induced by non-steroidal anti-inflammatory drugs in streptozotocin-diabetic and non-diabetic rats","volume":"102","author":"Ortiz","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2014.12.006_bib0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2007.02.023","article-title":"Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons","volume":"1148","author":"Park","year":"2007","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.pharep.2014.12.006_bib0260","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.neuroscience.2008.05.004","article-title":"Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons","volume":"154","author":"Frolov","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2008.02.072","article-title":"Does COX2-dependent PGE2 play a role in neuropathic pain?","volume":"437","author":"Ma","year":"2008","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.pharep.2014.12.006_bib0270","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.neuroscience.2007.01.054","article-title":"Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats","volume":"146","author":"Dong","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2014.12.006_bib0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2377-11-71","article-title":"Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3 expression and decreasing spinal microglial activation","volume":"11","author":"Cheng","year":"2011","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(00)00361-7","article-title":"Sildenafil produces antinociception and increases morphine antinociception in the formalin test","volume":"400","author":"Mixcoatl-Zecuatl","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2014.12.006_bib0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3959(99)00031-7","article-title":"Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats","volume":"82","author":"Lashbrook","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2014.12.006_bib0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ddr.20315","article-title":"Synergistic antiallodynic interaction of the metamizol-gabapentin combination","volume":"70","author":"Ortega-Varela","year":"2009","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharep.2014.12.006_bib0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/0470846682.ch13","article-title":"Therapeutic concentrations of local anaesthetics unveil the potential role of sodium channels in neuropathic pain","volume":"241","author":"Strichartz","year":"2002","journal-title":"Novartis Found Symp"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(87)90242-4","article-title":"Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones","volume":"83","author":"Dickenson","year":"1987","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.pharep.2014.12.006_bib0305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nm0912-1445c","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.pharep.2014.12.006_bib0310","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.2337\/db13-1158","article-title":"Location, location, location?: is the pain of diabetic neuropathy generated by hyperactive sensory neurons?","volume":"62","author":"Calcutt","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharep.2014.12.006_bib0315","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/jpet.104.075267","article-title":"The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl-]pyrazolo[1,5-bpyridazine] is effective in animal models of neuropathic pain and central sensitization","volume":"312","author":"Bingham","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.12.006_bib0320","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pain.2006.02.010","article-title":"Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs","volume":"123","author":"Chichorro","year":"2006","journal-title":"Pain"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014003776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:52Z","timestamp":1752611752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.12.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1734114014003776"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.12.006","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celecoxib reduces hyperalgesia and tactile allodynia in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}